Indeed, RIG-I and a related intracellular RNA-sensing molecular melanoma-differentiation factor 5 (MDA-5) have been discussed as potential players in amplifying anti-tumor immune responses following recognition of cancer-associated RNA structures (128, 129). This evidence concerns the gene RIGI and neoplasm.